BioCryst Pharmaceuticals | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Chugai Pharma JPY 135.83B 10.32B 2025-03
Daiichi Sankyo JPY 80.63B 1.78B 2025-03
DBV Technologies EUR -23008000 7.43M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Glaxosmithkline USD 1.66B 1.78B 2024-12
Incyte USD 234.19M 172.64M 2025-03
Ionis Pharmaceuticals USD -147000000 40M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



BioCryst Pharmaceuticals L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.